Supplementary Figure 3 from Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia

Autor:	Hagop M. Kantarjian, Elihu H. Estey, L. Austin Doyle, Steven M. Kornblau, Keith A. Baggerly, Wenbin Liu, Michael Andreeff, Jan A. Burger, LaKiesha Debose, Hongbo Lu, Jennie B. Feliu, Peter P. Ruvolo, Tapan M. Kadia, Xuelin Huang, Gautam Borthakur, Zhihong Zeng, Elias J. Jabbour, Stefan H. Faderl, Roland B. Walter, Marina Y. Konopleva
Rok vydání:	2023
DOI:	10.1158/1078-0432.22450359
Popis:	PDF file - 50KB, Correlation between RPPA and immunoblotting in samples from the patients treated on MK-2206 trial.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0b5b44254b7581e9f686bbaa95ef77d https://doi.org/10.1158/1078-0432.22450359 Zobrazit plný text záznamu